Associate Director, Clinical Data Science Compliance Oversight at Gilead Sciences

Foster City, California, United States

Gilead Sciences Logo
Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, PharmaceuticalsIndustries

Requirements

A Bachelor's degree with ten years of experience, a Master's degree with eight years of experience, or a PhD with two years of experience is required. Preferred qualifications include 10 years of relevant experience with a BS degree in life sciences or a related field, or 8 years of relevant experience with a Master's degree in life sciences or a related field, with significant experience advising biopharma business functions on quality and compliance requirements, evolving regulations, risk minimization and mitigation, and vendor management. Experience with authoring and reviewing SOPs, facilitating internal audits, supporting regulatory inspections, developing and managing CAPAs and deviations, and training others on quality and compliance requirements is also preferred.

Responsibilities

Lead the development and implementation of quality strategy and capabilities for Clinical Data Science (CDS) objectives. Manage the quality review of clinical trial documents, workflows, and outputs to ensure compliance with Gilead procedures, GCP, and global regulations. Analyze trends to identify process gaps, improvement opportunities, and areas requiring corrective/preventive actions. Lead new quality initiatives to continuously improve CDS quality practices. Provide expert advice on compliance issues and risk mitigation actions to CDS study teams. Collaborate with the audit, inspection, and CAPA management team on internal audits, regulatory inspections, risk assessment, deviations, and CAPA activities. Coordinate with business experts and stakeholders to support the resolution of audit outcomes. Serve as a Change Champion for Gilead QMS-related communications to the CDS organization. Analyze new regulations and policies, particularly GCP, and partner with stakeholders to update internal documentation and practices. Foster a commitment to quality within the CDS organization and with CDS-related service providers.

Skills

Quality Strategy
Clinical Trial Documentation
GCP
Regulatory Compliance
Process Improvement
Risk Mitigation
Audit Management
CAPA Management

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters
1987Year Founded
$15,873.6MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Paid family time off and paid parental time off
Generous 401(k) contribution matching
Comprehensive medical plans that cover both physical and mental healthcare
Global Wellbeing Reimbursement
Time Off
Global Volunteer Day
Giving Together Program
Employee Support Programs
Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.
Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.
Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.
Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.
Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.
Investment in digital health technologies enhances Gilead's R&D and patient engagement.
Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI